1Inada T,Imural J, lchikawa A, et al. Proliferating activity of gastric cancer assessed by immunostaining for prolfferting cell nuclear antigen[J]. J Surg Oncol, 1993,54(2) :145-152.
2Mitselou A ,loachim E,Kitsou E,et al. lmmunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices ( Ki67, PCNA) ,tumor suppressor genes(p53 ,pRb), the oncogene cerbB-2, sex steroid hormone receptors and other clini-copathological features,in normal, hyperplastic and neoplastic endometrium[ J]. In Vivo,2003,17(5) :469-477.
4Lee KE, Lee H J, Kim YH, et al. Prognostic significance of p53, nm23,PCNA and c-erbB-2 in gastric cancer[J]. Jpn J Clin Oncol, 2003,33(4) :173-179.
5Terada R,Yasutake T,Nakamra S,et al. Evalution of metastatic potertial of gastric tumor by staining for proliferating cell nuclear antigen and chromosome 17 numericsl aberratlons[J]. Ann Surg Oncol, 2001,8(6) :525-532.
6Fonseca GN, Srougi M, Leite KR, et al. The role of HER2/neu, BCL2,p53 genes and proliferating cell nuclear protein as molecular prognostic parameters in localized prostate carcinoma[J ]. Sao Paulo Med J,2004.,122(3) :124.-127.
1[1]Ebina M, steinberg, SM, Mulshine JL, et al. Relationship of p53overexprssion and up-repulation of PCNA with the clinical course of non-small cell lung cancer[J]. Res, 1994(54) :2496.
2[2]Thomas H, Nasin MM, Sarraf CE, et al. PCNA immunostaining: A prognostic factor in ovarian cancer[J]. Br J Cancer, 1995(71) :357.
3[3]Harris AL Mutant p53-the commonest abnormality in human cancer [J] .J Pathol, 1990(329) :219.
4[4]Levine AJ , Momand J , Finlay CA. The p53 tumor suppressor gene [J] . Nature , 1991 (351) :453 ～ 7.
5[5]Celis JE. Cell-dependent variations in the distributiom of the nuclear protein cyclin proliferating cell nuclear antigen in culttural cells :subdivision of S phase [J]. Proc Natl Acad Sci USA, 1985 (82):3262.
6[6]Zuber M , Tan EM , Ryoji M . Involvement of prolifreating cell nuclear antigen ( cyclin ) in DNA replicatiom in living cells [J].Mol Cell Biol , 1989(9):57.
7Dong JT, Lamb PW, Rinker Schaeffer CW, et al. KAIL a metastais gene for prostate cancer on human chromosome 11p11.2. Science,1995,268:884-886.
8Higashiyama M, Kodama K, Yokouchi H, et al. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis. Cancer, 1996 ,83(3):466-474.
9Zhou B, Liu L, Reddivari M, et al. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility - and invasiveness - inhibitory activity. Cancer Res, 2004 ,64(20):7455 - 7463.
10Nakamori S, Ishikawa O, Ohigashi H, et al. Clinicopathological feature and prognostic significance of nucleoside diphosphate kinase/nm23 gene product in human pancreatic endocrine neoplasm.Int J Panetratol, 1993,14:125 - 133.
